Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy.

[1]  M. Yacoub,et al.  Current state of the art and future of myectomy. , 2017, Annals of cardiothoracic surgery.

[2]  J. T. ten Berg,et al.  Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: A Word of Endorsement. , 2017, Journal of the American College of Cardiology.

[3]  B. Maron,et al.  Results of surgical septal myectomy for obstructive hypertrophic cardiomyopathy: the Tufts experience. , 2017, Annals of cardiothoracic surgery.

[4]  Jeroen J. Bax,et al.  Left Atrial Size and Function in Hypertrophic Cardiomyopathy Patients and Risk of New-Onset Atrial Fibrillation , 2017, Circulation. Arrhythmia and electrophysiology.

[5]  R. Contri,et al.  Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives , 2016, European journal of heart failure.

[6]  R. Swaminathan,et al.  Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy: US Nationwide Inpatient Database, 2003-2011. , 2016, JAMA cardiology.

[7]  M. Pencina,et al.  Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial. , 2016, American heart journal.

[8]  B. Maron,et al.  How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice. , 2016, JAMA cardiology.

[9]  M. P. van den Berg,et al.  Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly. , 2016, JACC. Cardiovascular interventions.

[10]  Christine E. Seidman,et al.  A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice , 2016, Science.

[11]  B. Mahmoodi,et al.  A Systematic Review and Meta-Analysis of Long-Term Outcomes After Septal Reduction Therapy in Patients With Hypertrophic Cardiomyopathy. , 2015, JACC. Heart failure.

[12]  F. Rutten,et al.  [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[13]  B. Gersh,et al.  Surgical myectomy improves pulmonary hypertension in obstructive hypertrophic cardiomyopathy. , 2014, European heart journal.

[14]  M. Enriquez-Sarano,et al.  Mitral valve repair in asymptomatic patients with severe mitral regurgitation: pushing past the tipping point. , 2014, Seminars in thoracic and cardiovascular surgery.

[15]  E. Ashley,et al.  Latent obstruction and left atrial size are predictors of clinical deterioration leading to septal reduction in hypertrophic cardiomyopathy. , 2014, Journal of cardiac failure.

[16]  M. Enriquez-Sarano,et al.  Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. , 2013, JAMA.

[17]  H. Rakowski,et al.  Surgical Myectomy for Hypertrophic Obstructive Cardiomyopathy: The Cut That Heals , 2013, Circulation.

[18]  M. Yacoub,et al.  Pattern and degree of left ventricular remodeling following a tailored surgical approach for hypertrophic obstructive cardiomyopathy , 2012, Global cardiology science & practice.

[19]  A. Gavazzi,et al.  A contemporary European experience with surgical septal myectomy in hypertrophic cardiomyopathy , 2012, European heart journal.

[20]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[21]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[22]  S. Ommen,et al.  Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy. , 2011, The Journal of thoracic and cardiovascular surgery.

[23]  W. Manning,et al.  Spectrum and clinical significance of systolic function and myocardial fibrosis assessed by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[24]  B. Gersh,et al.  Outcome of mildly symptomatic or asymptomatic obstructive hypertrophic cardiomyopathy: a long-term follow-up study. , 2009, Journal of the American College of Cardiology.

[25]  N. Smedira,et al.  Long-term outcomes in high-risk symptomatic patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation. , 2008, JACC. Cardiovascular interventions.

[26]  M. Link,et al.  Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction , 2006, Circulation.

[27]  P. Elliott,et al.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.

[28]  A. Tajik,et al.  Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[29]  W. Williams,et al.  Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy , 2005, Circulation.

[30]  B. Maron,et al.  Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[31]  B. Maron,et al.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[32]  J. Veselka,et al.  Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy : results from the Euro-ASA registry , 2019 .

[33]  M. Schemper,et al.  Asymptomatic Severe Aortic Stenosis in the Elderly. , 2017, JACC. Cardiovascular imaging.